JAMA Oncology Author Interviews
Health & Fitness:Medicine
Neratinib vs Trastuzumab for Untreated Metastatic ERBB2-Positive Breast Cancer
Interview with Ahmad Awada, MD, PhD, author of Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial, and Mark D. Pegram, MD, author of Neratinib in ERBB2-Positive Brain Metastases
Create your
podcast in
minutes
It is Free